Icon (ICLR) Interest Expenses (2009 - 2026)
Icon's (ICLR) quarterly Interest Expenses came in at -$48.8 million in Q2 2026, up 2.72% year-over-year from -$47.5 million in Q2 2025, and down 1.65% quarter-over-quarter from -$48.0 million in Q1 2026.
Analysis
Icon (ICLR) Interest Expenses (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Interest Expenses for 18 consecutive years, with -$48.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Expenses rose 2.72% year-over-year to -$48.8 million in Q2 2026; TTM through Jun 2026 was -$196.5 million, a 2.95% increase from a year earlier, with the FY2025 full-year figure at -$203.7 million, up 16.05% from the prior year.
- Interest Expenses was -$48.8 million for Q2 2026 at Icon, down from -$48.0 million in the prior quarter.
- Over five years, Interest Expenses peaked at $85.5 million in Q1 2023 and troughed at -$81.0 million in Q4 2023.
- A 5-year average of -$32.8 million and a median of -$49.8 million in 2025 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses sank 1529.08% in 2022 and surged 292.41% in 2023, its largest moves.
- Over 5 years, Interest Expenses stood at -$75.2 million in 2022, then fell by 7.78% to -$81.0 million in 2023, then soared by 36.53% to -$51.4 million in 2024, then grew by 3.78% to -$49.5 million in 2025, then advanced by 1.41% to -$48.8 million in 2026.
- The last three Interest Expenses figures came in at -$48.8 million (Q2 2026), -$48.0 million (Q1 2026), and -$49.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 197.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -48.79 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 30.34 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.79 Mn |
| Mar 31, 2026 | -48.00 Mn |
| Dec 31, 2025 | -49.49 Mn |
| Sep 30, 2025 | -50.24 Mn |
| Jun 30, 2025 | -50.15 Mn |
| Mar 31, 2025 | -47.61 Mn |
| Dec 31, 2024 | -51.43 Mn |
| Sep 30, 2024 | -53.30 Mn |
| Jun 30, 2024 | -60.84 Mn |
| Mar 31, 2024 | -71.67 Mn |
| Dec 31, 2023 | -81.03 Mn |
| Sep 30, 2023 | 82.64 Mn |
| Jun 30, 2023 | 84.26 Mn |
| Mar 31, 2023 | 85.48 Mn |
| Dec 31, 2022 | -75.19 Mn |
| Sep 30, 2022 | -63.01 Mn |
| Jun 30, 2022 | -47.11 Mn |
| Mar 31, 2022 | -44.43 Mn |
| Dec 31, 2021 | -52.84 Mn |
| Sep 30, 2021 | -102.31 Mn |